Shanton Pharma Receives EMA and FDA Pediatric Study Waivers for SAP-001 in Hyperuricemia

الملخص

Pediatric clinical studies of SAP-001 in hyperuricemia and gout are not needed Significant clinical trial burden and costs avoided due to waiver SINGAPORE and PRINCETON, N.J., Nov.